CLINICAL Leptospirosis Andrew Slack leptospirosis infections in Australia.2 Two new This article forms part of our travel medicine series for 2010, providing a summary of serovars have emerged in Australia over the prevention strategies and vaccination for infections that may be acquired by travellers. past decade: L. borgpetersenii sv. Arborea and L. The series aims to provide practical strategies to assist general practitioners in giving weilli sv. Topaz.2,5,6 Given the increasing scientific travel advice, as a synthesis of multiple information sources which must otherwise be knowledge of leptospirosis, clinical awareness consulted. needs to be drawn to the diagnosis, management Background and prevention of the disease. Leptospirosis is one of the many diseases responsible for undifferentiated febrile illness, especially in the tropical regions or in the returned traveller. It is a disease of Epidemiology global importance, and knowledge in the disease is continually developing. Leptospira has a worldwide distribution, occurring Objective in a range of climates. It is particularly prevalent in The aim of this article is to provide clinicians with a concise review of the epidemiology, tropical areas such as Southeast Asia, and locally pathophysiology, clinical features, diagnosis, management and prevention of in northern Queensland due to the high humidity, leptospirosis. rainfall and temperatures, which promote the Discussion survival of the organism.2 The average notification Leptospirosis should be included in the broad differential diagnosis of febrile illness. rate of leptospirosis is 0.85/100 000 population/ The clinical manifestations of the disease vary from mild, nonspecific illness through year in Australia (1991–2009), with Queensland to severe illness resulting in acute renal failure, hepatic failure and pulmonary having the highest notification rate of 2.45/100 haemorrhage. Diagnosis is dependant on accurate prediction of the time of infection: 000 population and the Australian Capital Territory culture, polymerase chain reaction and serology may be used to confirm the diagnosis. the lowest (0.06/100 000 population).7 Management is centred on prompt antibiotic therapy using doxycycline or intravenous Many animals have been reported as vectors penicillin G or intravenous ceftriaxone/cefotaxime. Prevention of leptospirosis revolves for Leptospira, including animals (cows, pigs, and around the ‘cover-wash-clean up’ strategy. sheep) and rodents such as rats and mice (both communicable/infectious diseases; tropical medicine; preventive medicine; Keywords: native and introduced species) and bandicoots, travel; leptospirosis possums, bats and kangaroos.2,6,8,9 Risk factors Risk factors for leptospirosis include: • occupation – high risk industries include Leptospirosis is the infection caused by cattle/dairy cow production, and banana the spirochaete genus of Leptospira. It was cultivation first identified in Germany in 1886 by Weil.1 • contact with animals – either direct contact Leptospirosis was first identified in Australia with animals or carcasses, or indirect contact in 1933 after an outbreak in the northern through contaminated urine/soil Queensland town of Ingham.2 Leptospirosis • recreational exposure – bushwalking, hunting, is considered an emerging infectious disease swimming, camping or adventure sports (eg. given its worldwide distribution and profound white water rafting). These activities result in effect on developing world medicine.3 prolonged exposure to contaminated soil and water The Leptospira genus is divided into 20 species • travel to regions with high rainfall/ of which nine are pathogenic.4 Serologically, temperatures – in Australia, the highest Leptospira are divided into over 200 serovars, incidence of leptospirosis occurs in the areas of which eight serovars cause the majority of surrounding Cairns in northern Queensland.2 Reprinted from AUstraliaN FamilY PHYsiciaN VOL. 39, NO. 7, JULY 2010 495 CLINICAL Leptospirosis Pathophysiology Culture/PCR IgM serology Microscopic agglutination test Leptospira enter the body via contact of the organism with abrasions or mucous membranes; Spiraemic phase often as a result of contact with Leptospira contaminated urine or soil. There is an Leptospira burden (blood) Anti-leptospira IgM incubation period of 2–20 days. This is followed Anti-leptospira IgG serological response / by a biphasic disease, with an acute spiraemic ) phase of approximately 7 days followed by an immunogenic phase characterised by the production of IgM and later IgG antibodies (Figure 1). The systemic illness is a consequence Organism burden (blood of Leptospira invading target organs such as the 5 10 15 20 kidneys, lungs and liver, resulting in a systemic Time since infection (days) vasculitic reaction with endothelial damage.1 Figure 1. Prototypic antibody response in Leptospirosis against time. Appropriate Clinical features and diagnostic testing for leptospirosis is dependant on accurate timing of infection complications Clinical symptoms vary from a nonspecific flu- specialised media. Typically several drops of microbiologist may be prudent before initiating like illness through to febrile illness. Typical aseptically collected blood are placed into PCR testing. symptoms reported in the acute spiraemic phase Ellinghausen McCullough Johnson Harris (EMJH) Serology include: fever, headaches, myalgias, rigors, media containing 0.5% agar. This is incubated arthalgia, nausea, vomiting and jaundice. Less for up to 1 month. It usually takes 1–2 weeks The majority of leptospirosis diagnoses in common signs include hepato-splenomegaly and incubation for sufficient organisms to be present Australia are made by serology. IgM antibodies lymphadenopathy.2 The most serious sequelae for visualisation under dark field microscopy. are detectable in sera within 5–10 days after occurs during the immune phase of the disease, Further identification to a serovar level requires infection (Figure 1). These can be detected by including acute renal failure, hepatic failure, complex serological testing which may take a commercially available ELISA kit. The ability aseptic meningitis and severe pulmonary months to be completed. Due to the 1–2 week of these assays to diagnose leptospirosis is hemorrhage syndrome.1 Fulminant leptospirosis delay in definitive diagnosis, culture is not dependant on when the sera was taken, past is uncommon in Australia due to the availability an optimal tool to determine the initiation of exposure to Leptospira (residual levels of and quality of critical care units. management, but remains useful in studying the IgM), and the potential of IgM cross reactivity epidemiology of the disease. with other diseases. There is no Leptospira Differential diagnosis specific IgG ELISA method available, however Polymerase chain reaction Given the nonspecific symptoms of leptospirosis confirmation of infection can be performed and tropical geography of infections, one must A polymerase chain reaction (PCR) test for using the microscopic agglutination test (MAT). entertain a large number of differential diagnoses leptospirosis is available at the WHO/FAO/OIE The MAT involves the reaction of antigens in including: malaria, dengue, cytomegalovirus, Collaborating Centre for Reference and Research the form of live Leptospira organisms with Epstein-Barr virus, typhoid, typhus, hepatitis, on Leptospirosis, Forensic and Scientific the antibodies found with the patient sera. A influenza, Q-fever, brucella, Ross River virus, Services, Coopers Plains, Queensland. Requests positive reaction will cause the Leptospira to Barmah Forest virus, Murray Valley encephalitis for Leptospira PCR testing can be referred to the agglutinate or clump and this can be viewed virus and Japanese encephalitis virus. laboratory by private pathology companies. This under dark ground microscopy. Dilutions of sera If the patient is a returning traveller from test has been evaluated alongside the Leptospira can be used to determine the titre of infection. overseas with a febrile illness, the list of IgM ELISA and culture for the early detection The MAT is typically serovar specific, and can differential diagnosis widens. For a review on this of leptospirosis and has a sensitivity of 96.4% be used to approximate the epidemiology of this subject refer to the article ‘Assessment of febrile and a specificity of 99.5% when compared to disease. The Public Health Laboratory Network illness in the returned traveller‘ by PA Leggat.10 culture (IgM ELISA has a sensitivity of 4.2% has developed a standard case definition for the and a specificity of 87.0% when compared to diagnosis of leptospirosis (Table 1).12 Diagnosis culture).11 Compared to ELISA, the caveat of Additional pathology testing Culture PCR testing is that it must be performed on samples likely to contain organisms – blood Additional testing should involve either serology During the spiraemic phase of the disease, from patients in the acute phase. Consultation or PCR testing (in the acute infection setting) it is possible to culture the organism using with an infectious disease physician or a clinical to exclude other pathogens, especially malaria. 496 Reprinted from AUstraliaN FamilY PHYsiciaN VOL. 39, NO. 7, JULY 2010 Leptospirosis CLINICAL Table 1. Case criteria for the diagnosis of leptospirosis12 for reducing leptospirosis in high risk environments has concluded that there was Definitive criteria an unclear benefit shown (with an increase in • Isolation of pathogenic